nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Estropipate—osteoporosis	0.122	0.181	CbGbCtD
Fosamprenavir—CYP3A4—Calcitriol—osteoporosis	0.122	0.181	CbGbCtD
Fosamprenavir—CYP3A4—Ergocalciferol—osteoporosis	0.0973	0.145	CbGbCtD
Fosamprenavir—CYP3A4—Raloxifene—osteoporosis	0.0812	0.121	CbGbCtD
Fosamprenavir—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0784	0.117	CbGbCtD
Fosamprenavir—CYP3A4—Cholecalciferol—osteoporosis	0.0627	0.0934	CbGbCtD
Fosamprenavir—CYP3A4—Conjugated Estrogens—osteoporosis	0.0575	0.0858	CbGbCtD
Fosamprenavir—CYP3A4—Estradiol—osteoporosis	0.0505	0.0753	CbGbCtD
Fosamprenavir—Skin disorder—Estropipate—osteoporosis	0.000811	0.00246	CcSEcCtD
Fosamprenavir—Malnutrition—Risedronate—osteoporosis	0.000808	0.00246	CcSEcCtD
Fosamprenavir—Immune system disorder—Pamidronate—osteoporosis	0.000797	0.00242	CcSEcCtD
Fosamprenavir—Flatulence—Risedronate—osteoporosis	0.000796	0.00242	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Zoledronate—osteoporosis	0.000796	0.00242	CcSEcCtD
Fosamprenavir—Gastritis—Estradiol—osteoporosis	0.000795	0.00241	CcSEcCtD
Fosamprenavir—Nervous system disorder—Raloxifene—osteoporosis	0.000793	0.00241	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Zoledronate—osteoporosis	0.000792	0.00241	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Estradiol—osteoporosis	0.000792	0.00241	CcSEcCtD
Fosamprenavir—Urethral disorder—Zoledronate—osteoporosis	0.00079	0.0024	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000789	0.0024	CcSEcCtD
Fosamprenavir—Skin disorder—Raloxifene—osteoporosis	0.000785	0.00239	CcSEcCtD
Fosamprenavir—Nervous system disorder—Ibandronate—osteoporosis	0.000785	0.00238	CcSEcCtD
Fosamprenavir—Skin disorder—Ibandronate—osteoporosis	0.000777	0.00236	CcSEcCtD
Fosamprenavir—Nausea—Ergocalciferol—osteoporosis	0.000771	0.00234	CcSEcCtD
Fosamprenavir—Malnutrition—Pamidronate—osteoporosis	0.000768	0.00233	CcSEcCtD
Fosamprenavir—Abdominal pain—Etidronic acid—osteoporosis	0.000763	0.00232	CcSEcCtD
Fosamprenavir—Skin disorder—Calcitriol—osteoporosis	0.000761	0.00231	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00076	0.00231	CcSEcCtD
Fosamprenavir—Angioedema—Ethinyl Estradiol—osteoporosis	0.000757	0.0023	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000749	0.00228	CcSEcCtD
Fosamprenavir—Cardiac disorder—Zoledronate—osteoporosis	0.000748	0.00227	CcSEcCtD
Fosamprenavir—Anorexia—Calcitriol—osteoporosis	0.000747	0.00227	CcSEcCtD
Fosamprenavir—Angioedema—Risedronate—osteoporosis	0.000738	0.00224	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000736	0.00224	CcSEcCtD
Fosamprenavir—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000734	0.00223	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000729	0.00222	CcSEcCtD
Fosamprenavir—Immune system disorder—Zoledronate—osteoporosis	0.000728	0.00221	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Estropipate—osteoporosis	0.00072	0.00219	CcSEcCtD
Fosamprenavir—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00072	0.00219	CcSEcCtD
Fosamprenavir—Fatigue—Estropipate—osteoporosis	0.000719	0.00219	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000714	0.00217	CcSEcCtD
Fosamprenavir—Hypersensitivity—Etidronic acid—osteoporosis	0.000711	0.00216	CcSEcCtD
Fosamprenavir—Angioedema—Pamidronate—osteoporosis	0.000702	0.00213	CcSEcCtD
Fosamprenavir—Malnutrition—Zoledronate—osteoporosis	0.000702	0.00213	CcSEcCtD
Fosamprenavir—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000701	0.00213	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000701	0.00213	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Estradiol—osteoporosis	0.0007	0.00213	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000698	0.00212	CcSEcCtD
Fosamprenavir—Decreased appetite—Ibandronate—osteoporosis	0.000696	0.00211	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000691	0.0021	CcSEcCtD
Fosamprenavir—Fatigue—Ibandronate—osteoporosis	0.00069	0.0021	CcSEcCtD
Fosamprenavir—Myalgia—Risedronate—osteoporosis	0.000688	0.00209	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000683	0.00208	CcSEcCtD
Fosamprenavir—Pruritus—Etidronic acid—osteoporosis	0.000682	0.00207	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Estropipate—osteoporosis	0.000682	0.00207	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Estradiol—osteoporosis	0.000682	0.00207	CcSEcCtD
Fosamprenavir—Decreased appetite—Calcitriol—osteoporosis	0.000681	0.00207	CcSEcCtD
Fosamprenavir—Myocardial infarction—Estradiol—osteoporosis	0.000678	0.00206	CcSEcCtD
Fosamprenavir—Malnutrition—Conjugated Estrogens—osteoporosis	0.000676	0.00205	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Alendronate—osteoporosis	0.000672	0.00204	CcSEcCtD
Fosamprenavir—Flatulence—Conjugated Estrogens—osteoporosis	0.000666	0.00202	CcSEcCtD
Fosamprenavir—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000663	0.00202	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Raloxifene—osteoporosis	0.000661	0.00201	CcSEcCtD
Fosamprenavir—Diarrhoea—Etidronic acid—osteoporosis	0.00066	0.00201	CcSEcCtD
Fosamprenavir—Body temperature increased—Estropipate—osteoporosis	0.00066	0.002	CcSEcCtD
Fosamprenavir—Abdominal pain—Estropipate—osteoporosis	0.00066	0.002	CcSEcCtD
Fosamprenavir—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000657	0.002	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Ibandronate—osteoporosis	0.000654	0.00199	CcSEcCtD
Fosamprenavir—Myalgia—Pamidronate—osteoporosis	0.000654	0.00199	CcSEcCtD
Fosamprenavir—Abdominal pain—Alendronate—osteoporosis	0.00065	0.00197	CcSEcCtD
Fosamprenavir—Body temperature increased—Alendronate—osteoporosis	0.00065	0.00197	CcSEcCtD
Fosamprenavir—Nervous system disorder—Risedronate—osteoporosis	0.000647	0.00196	CcSEcCtD
Fosamprenavir—Angioedema—Zoledronate—osteoporosis	0.000641	0.00195	CcSEcCtD
Fosamprenavir—Skin disorder—Risedronate—osteoporosis	0.000641	0.00195	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Calcitriol—osteoporosis	0.000641	0.00195	CcSEcCtD
Fosamprenavir—Abdominal pain—Raloxifene—osteoporosis	0.000639	0.00194	CcSEcCtD
Fosamprenavir—Body temperature increased—Raloxifene—osteoporosis	0.000639	0.00194	CcSEcCtD
Fosamprenavir—Body temperature increased—Ibandronate—osteoporosis	0.000633	0.00192	CcSEcCtD
Fosamprenavir—Abdominal pain—Ibandronate—osteoporosis	0.000633	0.00192	CcSEcCtD
Fosamprenavir—Haemoglobin—Estradiol—osteoporosis	0.000624	0.0019	CcSEcCtD
Fosamprenavir—Haemorrhage—Estradiol—osteoporosis	0.000621	0.00189	CcSEcCtD
Fosamprenavir—Abdominal pain—Calcitriol—osteoporosis	0.000619	0.00188	CcSEcCtD
Fosamprenavir—Body temperature increased—Calcitriol—osteoporosis	0.000619	0.00188	CcSEcCtD
Fosamprenavir—Angioedema—Conjugated Estrogens—osteoporosis	0.000617	0.00188	CcSEcCtD
Fosamprenavir—Hypersensitivity—Estropipate—osteoporosis	0.000615	0.00187	CcSEcCtD
Fosamprenavir—Nervous system disorder—Pamidronate—osteoporosis	0.000615	0.00187	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Estradiol—osteoporosis	0.000613	0.00186	CcSEcCtD
Fosamprenavir—Vomiting—Etidronic acid—osteoporosis	0.000613	0.00186	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Estradiol—osteoporosis	0.00061	0.00185	CcSEcCtD
Fosamprenavir—Urethral disorder—Estradiol—osteoporosis	0.000609	0.00185	CcSEcCtD
Fosamprenavir—Rash—Etidronic acid—osteoporosis	0.000608	0.00185	CcSEcCtD
Fosamprenavir—Dermatitis—Etidronic acid—osteoporosis	0.000608	0.00185	CcSEcCtD
Fosamprenavir—Hypersensitivity—Alendronate—osteoporosis	0.000606	0.00184	CcSEcCtD
Fosamprenavir—Headache—Etidronic acid—osteoporosis	0.000604	0.00184	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000601	0.00183	CcSEcCtD
Fosamprenavir—Asthenia—Estropipate—osteoporosis	0.000599	0.00182	CcSEcCtD
Fosamprenavir—Anorexia—Pamidronate—osteoporosis	0.000598	0.00182	CcSEcCtD
Fosamprenavir—Myalgia—Zoledronate—osteoporosis	0.000597	0.00181	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000593	0.0018	CcSEcCtD
Fosamprenavir—Pruritus—Estropipate—osteoporosis	0.00059	0.00179	CcSEcCtD
Fosamprenavir—Asthenia—Alendronate—osteoporosis	0.00059	0.00179	CcSEcCtD
Fosamprenavir—Hypersensitivity—Ibandronate—osteoporosis	0.00059	0.00179	CcSEcCtD
Fosamprenavir—Erythema multiforme—Estradiol—osteoporosis	0.000587	0.00178	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000584	0.00177	CcSEcCtD
Fosamprenavir—Fatigue—Ethinyl Estradiol—osteoporosis	0.000583	0.00177	CcSEcCtD
Fosamprenavir—Pruritus—Alendronate—osteoporosis	0.000581	0.00177	CcSEcCtD
Fosamprenavir—Hypersensitivity—Calcitriol—osteoporosis	0.000577	0.00175	CcSEcCtD
Fosamprenavir—Cardiac disorder—Estradiol—osteoporosis	0.000576	0.00175	CcSEcCtD
Fosamprenavir—Myalgia—Conjugated Estrogens—osteoporosis	0.000575	0.00175	CcSEcCtD
Fosamprenavir—Asthenia—Ibandronate—osteoporosis	0.000574	0.00174	CcSEcCtD
Fosamprenavir—Nausea—Etidronic acid—osteoporosis	0.000573	0.00174	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000571	0.00174	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000571	0.00174	CcSEcCtD
Fosamprenavir—Diarrhoea—Estropipate—osteoporosis	0.000571	0.00173	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Risedronate—osteoporosis	0.000569	0.00173	CcSEcCtD
Fosamprenavir—Fatigue—Risedronate—osteoporosis	0.000569	0.00173	CcSEcCtD
Fosamprenavir—Pruritus—Ibandronate—osteoporosis	0.000566	0.00172	CcSEcCtD
Fosamprenavir—Diarrhoea—Alendronate—osteoporosis	0.000562	0.00171	CcSEcCtD
Fosamprenavir—Asthenia—Calcitriol—osteoporosis	0.000562	0.00171	CcSEcCtD
Fosamprenavir—Nervous system disorder—Zoledronate—osteoporosis	0.000562	0.00171	CcSEcCtD
Fosamprenavir—Immune system disorder—Estradiol—osteoporosis	0.000561	0.0017	CcSEcCtD
Fosamprenavir—Skin disorder—Zoledronate—osteoporosis	0.000556	0.00169	CcSEcCtD
Fosamprenavir—Pruritus—Calcitriol—osteoporosis	0.000554	0.00168	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000553	0.00168	CcSEcCtD
Fosamprenavir—Diarrhoea—Raloxifene—osteoporosis	0.000553	0.00168	CcSEcCtD
Fosamprenavir—Dizziness—Estropipate—osteoporosis	0.000552	0.00168	CcSEcCtD
Fosamprenavir—Diarrhoea—Ibandronate—osteoporosis	0.000548	0.00166	CcSEcCtD
Fosamprenavir—Anorexia—Zoledronate—osteoporosis	0.000546	0.00166	CcSEcCtD
Fosamprenavir—Decreased appetite—Pamidronate—osteoporosis	0.000545	0.00166	CcSEcCtD
Fosamprenavir—Dizziness—Alendronate—osteoporosis	0.000543	0.00165	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000541	0.00164	CcSEcCtD
Fosamprenavir—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000541	0.00164	CcSEcCtD
Fosamprenavir—Malnutrition—Estradiol—osteoporosis	0.000541	0.00164	CcSEcCtD
Fosamprenavir—Fatigue—Pamidronate—osteoporosis	0.00054	0.00164	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Risedronate—osteoporosis	0.000539	0.00164	CcSEcCtD
Fosamprenavir—Diarrhoea—Calcitriol—osteoporosis	0.000536	0.00163	CcSEcCtD
Fosamprenavir—Skin disorder—Conjugated Estrogens—osteoporosis	0.000536	0.00163	CcSEcCtD
Fosamprenavir—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000535	0.00162	CcSEcCtD
Fosamprenavir—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000535	0.00162	CcSEcCtD
Fosamprenavir—Dizziness—Raloxifene—osteoporosis	0.000535	0.00162	CcSEcCtD
Fosamprenavir—Flatulence—Estradiol—osteoporosis	0.000533	0.00162	CcSEcCtD
Fosamprenavir—Vomiting—Estropipate—osteoporosis	0.000531	0.00161	CcSEcCtD
Fosamprenavir—Dizziness—Ibandronate—osteoporosis	0.000529	0.00161	CcSEcCtD
Fosamprenavir—Rash—Estropipate—osteoporosis	0.000526	0.0016	CcSEcCtD
Fosamprenavir—Dermatitis—Estropipate—osteoporosis	0.000526	0.0016	CcSEcCtD
Fosamprenavir—Anorexia—Conjugated Estrogens—osteoporosis	0.000526	0.0016	CcSEcCtD
Fosamprenavir—Headache—Estropipate—osteoporosis	0.000523	0.00159	CcSEcCtD
Fosamprenavir—Vomiting—Alendronate—osteoporosis	0.000523	0.00159	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000522	0.00159	CcSEcCtD
Fosamprenavir—Abdominal pain—Risedronate—osteoporosis	0.000521	0.00158	CcSEcCtD
Fosamprenavir—Body temperature increased—Risedronate—osteoporosis	0.000521	0.00158	CcSEcCtD
Fosamprenavir—Rash—Alendronate—osteoporosis	0.000518	0.00157	CcSEcCtD
Fosamprenavir—Dermatitis—Alendronate—osteoporosis	0.000518	0.00157	CcSEcCtD
Fosamprenavir—Headache—Alendronate—osteoporosis	0.000515	0.00156	CcSEcCtD
Fosamprenavir—Vomiting—Raloxifene—osteoporosis	0.000514	0.00156	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Pamidronate—osteoporosis	0.000513	0.00156	CcSEcCtD
Fosamprenavir—Rash—Raloxifene—osteoporosis	0.00051	0.00155	CcSEcCtD
Fosamprenavir—Dermatitis—Raloxifene—osteoporosis	0.000509	0.00155	CcSEcCtD
Fosamprenavir—Vomiting—Ibandronate—osteoporosis	0.000509	0.00155	CcSEcCtD
Fosamprenavir—Headache—Raloxifene—osteoporosis	0.000506	0.00154	CcSEcCtD
Fosamprenavir—Rash—Ibandronate—osteoporosis	0.000505	0.00153	CcSEcCtD
Fosamprenavir—Dermatitis—Ibandronate—osteoporosis	0.000504	0.00153	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000502	0.00153	CcSEcCtD
Fosamprenavir—Headache—Ibandronate—osteoporosis	0.000501	0.00152	CcSEcCtD
Fosamprenavir—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000498	0.00151	CcSEcCtD
Fosamprenavir—Vomiting—Calcitriol—osteoporosis	0.000498	0.00151	CcSEcCtD
Fosamprenavir—Decreased appetite—Zoledronate—osteoporosis	0.000498	0.00151	CcSEcCtD
Fosamprenavir—Nausea—Estropipate—osteoporosis	0.000496	0.00151	CcSEcCtD
Fosamprenavir—Abdominal pain—Pamidronate—osteoporosis	0.000496	0.00151	CcSEcCtD
Fosamprenavir—Body temperature increased—Pamidronate—osteoporosis	0.000496	0.00151	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000494	0.0015	CcSEcCtD
Fosamprenavir—Angioedema—Estradiol—osteoporosis	0.000494	0.0015	CcSEcCtD
Fosamprenavir—Rash—Calcitriol—osteoporosis	0.000494	0.0015	CcSEcCtD
Fosamprenavir—Fatigue—Zoledronate—osteoporosis	0.000494	0.0015	CcSEcCtD
Fosamprenavir—Dermatitis—Calcitriol—osteoporosis	0.000493	0.0015	CcSEcCtD
Fosamprenavir—Headache—Calcitriol—osteoporosis	0.000491	0.00149	CcSEcCtD
Fosamprenavir—Nausea—Alendronate—osteoporosis	0.000488	0.00148	CcSEcCtD
Fosamprenavir—Hypersensitivity—Risedronate—osteoporosis	0.000486	0.00148	CcSEcCtD
Fosamprenavir—Asthenia—Ethinyl Estradiol—osteoporosis	0.000485	0.00147	CcSEcCtD
Fosamprenavir—Nausea—Raloxifene—osteoporosis	0.00048	0.00146	CcSEcCtD
Fosamprenavir—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000479	0.00146	CcSEcCtD
Fosamprenavir—Pruritus—Ethinyl Estradiol—osteoporosis	0.000479	0.00145	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000476	0.00145	CcSEcCtD
Fosamprenavir—Fatigue—Conjugated Estrogens—osteoporosis	0.000475	0.00144	CcSEcCtD
Fosamprenavir—Nausea—Ibandronate—osteoporosis	0.000475	0.00144	CcSEcCtD
Fosamprenavir—Asthenia—Risedronate—osteoporosis	0.000473	0.00144	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Zoledronate—osteoporosis	0.000468	0.00142	CcSEcCtD
Fosamprenavir—Pruritus—Risedronate—osteoporosis	0.000467	0.00142	CcSEcCtD
Fosamprenavir—Nausea—Calcitriol—osteoporosis	0.000465	0.00141	CcSEcCtD
Fosamprenavir—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000463	0.00141	CcSEcCtD
Fosamprenavir—Hypersensitivity—Pamidronate—osteoporosis	0.000462	0.0014	CcSEcCtD
Fosamprenavir—Myalgia—Estradiol—osteoporosis	0.00046	0.0014	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000457	0.00139	CcSEcCtD
Fosamprenavir—Body temperature increased—Zoledronate—osteoporosis	0.000453	0.00138	CcSEcCtD
Fosamprenavir—Abdominal pain—Zoledronate—osteoporosis	0.000453	0.00138	CcSEcCtD
Fosamprenavir—Diarrhoea—Risedronate—osteoporosis	0.000451	0.00137	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000451	0.00137	CcSEcCtD
Fosamprenavir—Asthenia—Pamidronate—osteoporosis	0.00045	0.00137	CcSEcCtD
Fosamprenavir—Dizziness—Ethinyl Estradiol—osteoporosis	0.000447	0.00136	CcSEcCtD
Fosamprenavir—Pruritus—Pamidronate—osteoporosis	0.000444	0.00135	CcSEcCtD
Fosamprenavir—Dizziness—Risedronate—osteoporosis	0.000436	0.00132	CcSEcCtD
Fosamprenavir—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000436	0.00132	CcSEcCtD
Fosamprenavir—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000436	0.00132	CcSEcCtD
Fosamprenavir—Nervous system disorder—Estradiol—osteoporosis	0.000433	0.00131	CcSEcCtD
Fosamprenavir—Vomiting—Ethinyl Estradiol—osteoporosis	0.00043	0.00131	CcSEcCtD
Fosamprenavir—Diarrhoea—Pamidronate—osteoporosis	0.000429	0.0013	CcSEcCtD
Fosamprenavir—Skin disorder—Estradiol—osteoporosis	0.000429	0.0013	CcSEcCtD
Fosamprenavir—Rash—Ethinyl Estradiol—osteoporosis	0.000426	0.0013	CcSEcCtD
Fosamprenavir—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000426	0.00129	CcSEcCtD
Fosamprenavir—Headache—Ethinyl Estradiol—osteoporosis	0.000424	0.00129	CcSEcCtD
Fosamprenavir—Hypersensitivity—Zoledronate—osteoporosis	0.000422	0.00128	CcSEcCtD
Fosamprenavir—Vomiting—Risedronate—osteoporosis	0.000419	0.00127	CcSEcCtD
Fosamprenavir—Rash—Risedronate—osteoporosis	0.000416	0.00126	CcSEcCtD
Fosamprenavir—Dermatitis—Risedronate—osteoporosis	0.000415	0.00126	CcSEcCtD
Fosamprenavir—Dizziness—Pamidronate—osteoporosis	0.000415	0.00126	CcSEcCtD
Fosamprenavir—Headache—Risedronate—osteoporosis	0.000413	0.00126	CcSEcCtD
Fosamprenavir—Asthenia—Zoledronate—osteoporosis	0.000411	0.00125	CcSEcCtD
Fosamprenavir—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000406	0.00123	CcSEcCtD
Fosamprenavir—Pruritus—Zoledronate—osteoporosis	0.000405	0.00123	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000402	0.00122	CcSEcCtD
Fosamprenavir—Nausea—Ethinyl Estradiol—osteoporosis	0.000402	0.00122	CcSEcCtD
Fosamprenavir—Vomiting—Pamidronate—osteoporosis	0.000399	0.00121	CcSEcCtD
Fosamprenavir—Asthenia—Conjugated Estrogens—osteoporosis	0.000396	0.0012	CcSEcCtD
Fosamprenavir—Rash—Pamidronate—osteoporosis	0.000395	0.0012	CcSEcCtD
Fosamprenavir—Dermatitis—Pamidronate—osteoporosis	0.000395	0.0012	CcSEcCtD
Fosamprenavir—Headache—Pamidronate—osteoporosis	0.000393	0.00119	CcSEcCtD
Fosamprenavir—Diarrhoea—Zoledronate—osteoporosis	0.000392	0.00119	CcSEcCtD
Fosamprenavir—Nausea—Risedronate—osteoporosis	0.000392	0.00119	CcSEcCtD
Fosamprenavir—Pruritus—Conjugated Estrogens—osteoporosis	0.00039	0.00119	CcSEcCtD
Fosamprenavir—Decreased appetite—Estradiol—osteoporosis	0.000384	0.00117	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Estradiol—osteoporosis	0.000381	0.00116	CcSEcCtD
Fosamprenavir—Fatigue—Estradiol—osteoporosis	0.00038	0.00116	CcSEcCtD
Fosamprenavir—Dizziness—Zoledronate—osteoporosis	0.000379	0.00115	CcSEcCtD
Fosamprenavir—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000377	0.00115	CcSEcCtD
Fosamprenavir—Nausea—Pamidronate—osteoporosis	0.000372	0.00113	CcSEcCtD
Fosamprenavir—Dizziness—Conjugated Estrogens—osteoporosis	0.000365	0.00111	CcSEcCtD
Fosamprenavir—Vomiting—Zoledronate—osteoporosis	0.000364	0.00111	CcSEcCtD
Fosamprenavir—Rash—Zoledronate—osteoporosis	0.000361	0.0011	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Estradiol—osteoporosis	0.000361	0.0011	CcSEcCtD
Fosamprenavir—Dermatitis—Zoledronate—osteoporosis	0.000361	0.0011	CcSEcCtD
Fosamprenavir—Headache—Zoledronate—osteoporosis	0.000359	0.00109	CcSEcCtD
Fosamprenavir—Vomiting—Conjugated Estrogens—osteoporosis	0.000351	0.00107	CcSEcCtD
Fosamprenavir—Body temperature increased—Estradiol—osteoporosis	0.000349	0.00106	CcSEcCtD
Fosamprenavir—Abdominal pain—Estradiol—osteoporosis	0.000349	0.00106	CcSEcCtD
Fosamprenavir—Rash—Conjugated Estrogens—osteoporosis	0.000348	0.00106	CcSEcCtD
Fosamprenavir—Dermatitis—Conjugated Estrogens—osteoporosis	0.000347	0.00106	CcSEcCtD
Fosamprenavir—Headache—Conjugated Estrogens—osteoporosis	0.000345	0.00105	CcSEcCtD
Fosamprenavir—Nausea—Zoledronate—osteoporosis	0.00034	0.00103	CcSEcCtD
Fosamprenavir—Nausea—Conjugated Estrogens—osteoporosis	0.000328	0.000995	CcSEcCtD
Fosamprenavir—Hypersensitivity—Estradiol—osteoporosis	0.000325	0.000988	CcSEcCtD
Fosamprenavir—Asthenia—Estradiol—osteoporosis	0.000317	0.000962	CcSEcCtD
Fosamprenavir—Pruritus—Estradiol—osteoporosis	0.000312	0.000949	CcSEcCtD
Fosamprenavir—Diarrhoea—Estradiol—osteoporosis	0.000302	0.000917	CcSEcCtD
Fosamprenavir—Dizziness—Estradiol—osteoporosis	0.000292	0.000887	CcSEcCtD
Fosamprenavir—Vomiting—Estradiol—osteoporosis	0.000281	0.000852	CcSEcCtD
Fosamprenavir—Rash—Estradiol—osteoporosis	0.000278	0.000845	CcSEcCtD
Fosamprenavir—Dermatitis—Estradiol—osteoporosis	0.000278	0.000845	CcSEcCtD
Fosamprenavir—Headache—Estradiol—osteoporosis	0.000276	0.00084	CcSEcCtD
Fosamprenavir—Nausea—Estradiol—osteoporosis	0.000262	0.000796	CcSEcCtD
